Press Releases :: VolitionRx Ltd (VNRX)

May 4, 2018 • 8:00 AM EDT VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update

Mar 13, 2018 • 4:05 PM EDT VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock

Mar 9, 2018 • 9:10 AM EST VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock

Mar 8, 2018 • 4:01 PM EST VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

Mar 7, 2018 • 8:30 AM EST VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board

Mar 1, 2018 • 4:05 PM EST VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update

Feb 28, 2018 • 4:05 PM EST VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update

Feb 26, 2018 • 4:05 PM EST VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer

Feb 5, 2018 • 8:30 AM EST VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.

Jan 3, 2018 • 8:30 AM EST VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone

« Previous
1
2
3
4
5
6
7
8
9
10
...22
Next »